BI's Spiriva Gets Advisory Panel Nod For COPD Exacerbations Despite Statistical Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Committee finds clinical trial safety results more compelling than meta-analysis, and is undeterred by the lack of statistical significance in the study's primary endpoints.